Eterna Therapeutics Files Definitive Proxy Statement

TL;DR

Eterna Therapeutics (ETRN) filed its proxy statement. Standard shareholder vote stuff.

AI Summary

Eterna Therapeutics Inc. filed a Definitive Proxy Statement (DEF 14A) on October 7, 2024. The filing concerns the company's proxy materials, which are typically used for shareholder meetings to vote on corporate matters. Eterna Therapeutics Inc. was formerly known as Brooklyn ImmunoTherapeutics, Inc. until March 25, 2021.

Why It Matters

This filing is a standard regulatory requirement for public companies and provides shareholders with information necessary for upcoming votes, impacting corporate governance.

Risk Assessment

Risk Level: low — This is a routine regulatory filing (DEF 14A) and does not contain new financial or operational information that would inherently increase risk.

Key Players & Entities

• Eterna Therapeutics Inc. (company) — Registrant
• Brooklyn ImmunoTherapeutics, Inc. (company) — Former company name
• October 7, 2024 (date) — Filing date
• 20210325 (date) — Date of name change from Brooklyn ImmunoTherapeutics, Inc.

FAQ

Filing Documents

• formdef14a.htm (DEF 14A) — 608KB
• formdef14a_001.jpg (GRAPHIC) — 68KB
• formdef14a_002.jpg (GRAPHIC) — 55KB
• formdef14a_003.jpg (GRAPHIC) — 232KB
• proxycard_001.jpg (GRAPHIC) — 2990KB
• proxycard_002.jpg (GRAPHIC) — 1718KB
• 0001493152-24-040286.txt ( ) — 7567KB

Executive Compensation

Executive Compensation 17 Pay Versus Performance 22 Director Compensation 26 Proposal No. 1 - Election of Directors 27 Proposal No. 2 - Ratification of Auditors Proposal 28 Proposal No. 3 - Stock Issuance Proposal 30 Where To Get Additional Information 35 Annual Report 35 Other Business 35 i ETERNA THERAPEUTICS INC. PROXY 2024 ANNUAL MEETING OF STOCKHOLDERS To Be Held On October 29, 2024 You are receiving this proxy statement because you owned shares of common stock of Eterna Therapeutics Inc., a Delaware corporation (“we,” “us,” “our” or the “Company”), as of October 1, 2024, which entitles you to vote those shares at the 2024 annual meeting of stockholders to be held on October 29, 2024, at 9:00 a.m. Eastern Time. In this proxy statement, we refer to the 2024 annual meeting of stockholders and any adjournments of or postponements thereof as the “meeting” or “annual meeting.” Our proxy materials will be first sent or given to stockholders on or about October 7, 2024. We are soliciting proxies pursuant to this proxy statement for use at the annual meeting. Our Internet website and the information contained therein or linked thereto are not incorporated by reference or otherwise made a part of this proxy statement. INFORMATION ABOUT THE MEETING When and where is the annual meeting? The annual meeting will be held on October 29, 2024, at 9:00 a.m. Eastern Time. The annual meeting will be a completely virtual meeting conducted via live audio webcast. You will be able to attend the annual meeting by visiting virtualshareholdermeeting.com/ERNA2024 . There will still not be a physical location for the annual meeting. To participate in the annual meeting, you will need the 16-digit control number included on your proxy card or voting instruction form. The annual meeting will begin promptly at 9:00 a.m. Eastern Time on October 29, 2024. We encou

View Full Filing

View this DEF 14A filing on SEC EDGAR